Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2021-10-29 Major Shareholding Noti…
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Medistim ASA: Disclosure of large shareholding
Major Shareholding Notification Classification · 98% confidence The document explicitly states 'Disclosure of large shareholding' and details a transaction where one entity (Intertrade Shipping AS) sold shares to its wholly-owned subsidiary (Fløtemarken AS), resulting in the subsidiary owning 7% of the issued shares. This type of notification, concerning changes in significant share ownership thresholds or major holdings by related parties, directly corresponds to the definition of Major Shareholding Notification (MRQ). The document length is very short (788 chars), but the content is a direct notification of a holding change, not an announcement about the publication of a report.
2021-10-29 English
Third quarter results 2021 for Medistim ASA
Interim / Quarterly Report Classification · 100% confidence The document is a presentation titled 'Medistim ASA's Interim report Q3 2021'. It contains detailed financial statements (Profit and Loss, Balance Sheet), business segment updates, and regional performance analysis for the third quarter of 2021. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q3 2021
2021-10-22 English
Third quarter results 2021 for Medistim ASA
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT' and 'THIRD QUARTER REPORT 2021'. It contains detailed financial statements, including sales revenues, EBIT, cash flow, balance sheet data, and operational status for the quarter ended September 2021. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q3 2021
2021-10-22 English
Third quarter results 2021 for Medistim ASA
Earnings Release Classification · 100% confidence The document text explicitly states 'Third quarter results 2021 for Medistim ASA' and provides key financial metrics for the quarter (Sales revenues, Operating result (EBIT), Cash flow) and Year-to-Date (YTD) figures. This content structure, focusing on period-specific financial performance highlights, aligns perfectly with an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). It is too brief and focused on highlights to be a comprehensive Interim Report (IR). Q3 2021
2021-10-22 English
Pivotal consensus statement for Medistim’s transit time flow technology (TTFM) published in Circulation
Regulatory Filings Classification · 100% confidence The document is a press release from Medistim ASA announcing that a pivotal consensus statement regarding their TTFM technology was published in the journal 'Circulation'. It details the significance of this publication for their strategy and provides a link to the external publication. Since this is an announcement about external research/guidelines and not a formal regulatory filing (like 10-K, IR, or ER), nor is it a management change (MANG) or dividend notice (DIV), it best fits the category for general regulatory or informational announcements that don't fit elsewhere. Given the options, 'Regulatory Filings' (RNS) serves as the most appropriate general announcement/news category for this type of corporate communication that is not a core financial report or specific corporate action.
2021-10-19 English
Presentation of third quarter results 2021 for Medistim ASA
Report Publication Announcement Classification · 95% confidence The document text is very short (720 characters) and explicitly invites participants to a 'Presentation of third quarter results 2021' via a webinar. It details the date, time, and registration link for this event, featuring the CEO and CFO. This structure strongly suggests an announcement about an upcoming event where results will be discussed, rather than the full financial report (IR) or the transcript of the call itself (CT). Since it is an announcement related to the release of periodic results (third quarter), and it is not the full report, it fits best as an Investor Presentation (IP) announcement or potentially a Report Publication Announcement (RPA) if the focus is purely on the announcement mechanism. Given the context of presenting results, 'Investor Presentation' (IP) is a strong fit for the material being presented, but since this is the *invitation* to the presentation, and not the presentation slides themselves, 'RPA' (Report Publication Announcement) is often used for announcements of upcoming result briefings. However, since the content is specifically about the presentation of quarterly results, and 'IP' covers investor presentations, I will lean towards the nature of the event being announced. Since the document is an invitation to a presentation of results, and not the results themselves, and it is not a generic regulatory filing, I will classify it as an Investor Presentation (IP) announcement, or RPA. Given the options, and the focus on the presentation event, RPA is the most accurate fit for the announcement itself, as per Rule 2 (Menu vs Meal).
2021-10-18 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.